MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41436-018-0384-y

Медицинская библиотека · Genetics in medicine : official journal of the American College of Medical Genetics · 2018

Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing.

Evans D Gareth, King Andrew T, Bowers Naomi L, Tobi Simon, Wallace Andrew J, Perry Mary, Anup Raji, Lloyd Simon K L, Rutherford Scott A, Hammerbeck-Ward Charlotte, Pathmanaban Omar N, Stapleton Emma, Freeman Simon R, Kellett Mark, Halliday Dorothy, Parry Allyson, Gair Juliette J, Axon Patrick, Laitt Roger, Thomas Owen, Afridi Shazia, Ferner Rosalie E, Harkness Elaine F, Smith Miriam J, English Specialist NF2 Research Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: We have evaluated deficiencies in existing diagnostic criteria for neurofibromatosis 2 (NF2).

METHODS

Two large databases of individuals fulfilling NF2 criteria (n = 1361) and those tested for NF2 variants with criteria short of diagnosis (n = 1416) were interrogated. We assessed the proportions meeting each diagnostic criterion with constitutional or mosaic NF2 variants and the positive predictive value (PPV) with regard to definite diagnosis.

RESULTS

There was no evidence for usefulness of old criteria "glioma" or "neurofibroma." "Ependymoma" had 100% PPV and high levels of confirmed NF2 diagnosis (67.7%). Those with bilateral vestibular schwannoma (VS) alone aged ≥60 years had the lowest confirmation rate (6.6%) and reduced PPV (80%). Siblings as a first-degree relative, without an affected parent, had 0% PPV. All three individuals with unilateral VS and an affected sibling were proven not to have NF2. The biggest overlap was with LZTR1-associated schwannomatosis. In this category, seven individuals with unilateral VS plus ≥2 nondermal schwannomas reduced PPV to 67%.

CONCLUSIONS

The present study confirms important deficiencies in NF2 diagnostic criteria. The term "glioma" should be dropped and replaced by "ependymoma." Similarly "neurofibroma" should be removed. Dropping "sibling" from first-degree relatives should be considered and testing of LZTR1 should be recommended for unilateral VS.

Для цитирования: Evans D Gareth, King Andrew T, Bowers Naomi L, Tobi Simon, Wallace Andrew J, Perry Mary, Anup Raji, Lloyd Simon K L, Rutherford Scott A, Hammerbeck-Ward Charlotte, Pathmanaban Omar N, Stapleton Emma, Freeman Simon R, Kellett Mark, Halliday Dorothy, Parry Allyson, Gair Juliette J, Axon Patrick, Laitt Roger, Thomas Owen, Afridi Shazia, Ferner Rosalie E, Harkness Elaine F, Smith Miriam J, English Specialist NF2 Research Group. Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing.. Genetics in medicine : official journal of the American College of Medical Genetics. 2018. DOI: 10.1038/s41436-018-0384-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.